Transient effusive-constrictive pericarditis due to chemotherapy

Clin Cardiol. 1999 Apr;22(4):316-8. doi: 10.1002/clc.4960220414.

Abstract

Commonly used chemotherapeutic agents, specifically cytarabine and daunorubicin, can cause effusive-constrictive pericarditis. We describe a case of transient effusive-constrictive pericarditis in a patient with acute myelogenous leukemia. This is the first case report of a patient with transient effusive-constrictive pericarditis due to chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Echocardiography
  • Follow-Up Studies
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Middle Aged
  • Pericardial Effusion / chemically induced*
  • Pericardial Effusion / diagnosis
  • Pericardial Effusion / therapy
  • Pericarditis, Constrictive / chemically induced*
  • Pericarditis, Constrictive / diagnosis
  • Pericarditis, Constrictive / therapy
  • Tomography, X-Ray Computed

Substances

  • Antibiotics, Antineoplastic
  • Antimetabolites, Antineoplastic
  • Cytarabine
  • Daunorubicin